Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1993 1
1996 1
1997 1
1998 3
1999 1
2000 3
2001 1
2002 2
2003 2
2004 4
2005 4
2006 3
2007 1
2008 1
2009 1
2010 1
2011 2
2012 2
2013 3
2014 1
2015 1
2016 1
2019 2
2021 5
2022 6
2024 1
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Tarasoff in Texas.
Felthous AR, Scarano VR. Felthous AR, et al. Among authors: scarano vr. Tex Med. 1999 Mar;95(3):72-8. Tex Med. 1999. PMID: 10932639
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study.
Abbadessa G, Schiavetti I, Bollo L, Cellerino M, Miele G, Zanghì A, Cavalla P, Signori A, Bulgari A, Trotta M, Scarano V, Fantozzi R, Landi D, Smolik K, Clerici VT, De Luca G, Marinelli F, Buttari F, Clerico M, Ferrazzano G, Buscarinu MC, Pasquali L, Tomasso I, Vercellino M, Maida E, Bile F, Lavorgna L, D'Amico E, Inglese M, Sormani MP, Iaffaldano P, Bonavita S; S1PRm study group. Abbadessa G, et al. Among authors: scarano v. J Neurol Sci. 2025 Jul 15;474:123533. doi: 10.1016/j.jns.2025.123533. Epub 2025 May 10. J Neurol Sci. 2025. PMID: 40373481 Free article.
[Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register].
Ponzio M, Battaglia MA, Trojano M, Salivetto M, D'Ettorre A, Corrado D, Paletta P, Lepore V, Mosconi P; Comitato Scientifico del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete dei centri del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete degli assistenti di ricerca del Registro Italiano Sclerosi Multipla e Patologie Correlate. Ponzio M, et al. Epidemiol Prev. 2024 Jul-Oct;48(4-5):361-374. doi: 10.19191/EP24.4-5.A734.074. Epidemiol Prev. 2024. PMID: 39329242 Free article. Italian.
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.
Maniscalco GT, Sparaco M, Di Gregorio M, Cafasso G, Signoriello E, Romano F, Iodice R, Fantozzi R, Bellantonio P, Zanghi A, Sinisi L, D'Ambrosio A, Busillo V, Scarano V, Capuano R, Lavorgna L, Williams M, De Martino A, Di Battista ME, Di Giulio Cesare D, Lus G, Cassano E, Di Filippo PS, Sibilia G, Abbadessa G, Andreone V, Bonavita S. Maniscalco GT, et al. Among authors: scarano v. J Neurol. 2025 Aug 6;272(9):559. doi: 10.1007/s00415-025-13300-z. J Neurol. 2025. PMID: 40770143 Free PMC article.
Towards the online computer-aided design of catalytic pockets.
Falivene L, Cao Z, Petta A, Serra L, Poater A, Oliva R, Scarano V, Cavallo L. Falivene L, et al. Among authors: scarano v. Nat Chem. 2019 Oct;11(10):872-879. doi: 10.1038/s41557-019-0319-5. Epub 2019 Sep 2. Nat Chem. 2019. PMID: 31477851 Review.
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.
Portaccio E, Betti M, De Meo E, Pastò L, Prestipino E, Lugaresi A, Cocco E, De Luca G, Patti F, Torri Clerici VLAM, Ferraro D, Brescia Morra V, Salemi G, Vianello M, Cerqua R, Inglese M, Pasanisi MB, Perini P, Romano S, Pozzilli C, Tortorella C, Di Sapio A, Annovazzi P, Simone M, Iaffaldano P, Rocca MA, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis and Related Disorders Register. Portaccio E, et al. Neurology. 2025 Oct 21;105(8):e213977. doi: 10.1212/WNL.0000000000213977. Epub 2025 Sep 22. Neurology. 2025. PMID: 40982769 Free PMC article.
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.
Sormani MP, Schiavetti I, Carmisciano L, Cordioli C, Filippi M, Radaelli M, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Cocco E, Scandellari C, Cavalla P, Pesci I, Zito A, Confalonieri P, Marfia GA, Perini P, Inglese M, Trojano M, Brescia Morra V, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34753829 Free PMC article.
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Schiavetti I, Carmisciano L, Ponzano M, Cordioli C, Cocco E, Marfia GA, Inglese M, Filippi M, Radaelli M, Bergamaschi R, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Scandellari C, Cavalla P, Pesci I, Confalonieri P, Perini P, Trojano M, Lanzillo R, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M, Sormani MP; MuSC-19 Study Group. Schiavetti I, et al. Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23. Eur J Neurol. 2022. PMID: 36086905 Free PMC article.
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Brescia Morra V, Trojano M, Tedeschi G, Comi G, Battaglia MA, Patti F, Fragoso YD, Sen S, Siva A, Furlan R, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Mult Scler. 2022 Jun;28(7):1034-1040. doi: 10.1177/13524585211035318. Epub 2021 Jul 30. Mult Scler. 2022. PMID: 34328824
54 results